Hyperbilirubinemia, Neonatal
37
3
3
25
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.7%
1 terminated out of 37 trials
96.2%
+9.6% vs benchmark
8%
3 trials in Phase 3/4
8%
2 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (37)
White Cover & Massage Effects on Bilirubin and Phototherapy in ABO-Incompatible Newborns
Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice
White Cover and Massage Impact on Bilirubin Levels and Phototherapy Duration in Newborns
TCB Self-Monitoring in Healthy Term and Near-Term Neonates
The Effect of Position Change Frequency on Hyperbilirubinemia
Effect of Probiotic Lacobacillus Reuterii on Serum Bilirubin Levels in Preterm Infants
The Effect of Massage on the Bilirubin Level in Term Infants Receiving Phototherapy
Effects of Oil and Dry Neonatal Massage on Hyperbilirubinemia and Comfort
Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).
Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
Hyperbilirubinemia in Full-term Neonates
Effectiveness of Phototherapy With and Without Probiotics
Transcutaneous Bilirubin Levels From Covered Skin
The Efficacy of Oral Probiotics on Neonatal Hyperbilirubinemia
A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns
Identification of Jaundice in Newborns Using Smartphones
Intelligent Follow-up of Neonatal Jaundice Based on Early Indicators and Internet Communications
Bundling Gentle Body Massage Along With Regular Position Change Under Phototherapy
Multi-center Clinical Study on Neonatal Hyperbilirubinemia